BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30187133)

  • 1. Comparison of contrast-enhanced ultrasound targeted biopsy versus standard systematic biopsy for clinically significant prostate cancer detection: results of a prospective cohort study with 1024 patients.
    Yunkai Z; Yaqing C; Jun J; Tingyue Q; Weiyong L; Yuehong Q; Wenbin G; Lifeng W; Jun Q
    World J Urol; 2019 May; 37(5):805-811. PubMed ID: 30187133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of contrast-enhanced ultrasound targeted biopsies versus standard systematic biopsies for prostate cancer correction in different PSA value groups in rural China.
    Lu DY; Liu L; Shen L; Cai JR; Xu L; Xiang LH
    Clin Hemorheol Microcirc; 2021; 77(3):295-301. PubMed ID: 33252065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
    Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
    Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain Elastography-Targeted Biopsy: Does Prostate Volume Affect Prostate Cancer Detection?
    Zhu YC; Shan J; Zhang Y; Jiang Q; Wang YB; Deng SH; Qu QH; Li Q
    Med Sci Monit; 2019 Nov; 25():8836-8842. PubMed ID: 31754091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
    von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
    Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can fewer transperineal systematic biopsy cores have the same prostate cancer detection rate as of magnetic resonance imaging/ultrasound fusion biopsy?
    Liu H; Ruan M; Wang H; Wang H; Li X; Song G
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):589-595. PubMed ID: 32719353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate.
    Wang L; Wang X; Zhao W; Zhao Z; Li Z; Fei S; Zhu H; Ji X; Yang B; Li N; Na Y
    BMC Urol; 2019 Nov; 19(1):107. PubMed ID: 31684917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prostate cancer detection rates of CEUS-targeted versus MRI-targeted versus systematic TRUS-guided biopsies in biopsy-naïve men: a prospective, comparative clinical trial using the same patients.
    Postema AW; Scheltema MJ; Mannaerts CK; Van Sloun RJ; Idzenga T; Mischi M; Engelbrecht MR; De la Rosette JJ; Wijkstra H
    BMC Urol; 2017 Apr; 17(1):27. PubMed ID: 28381220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of MRI/ultrasound fusion in primary biopsy for the diagnosis of prostate cancer].
    Distler F; Radtke JP; Kesch C; Roethke M; Schlemmer HP; Roth W; Hohenfellner M; Hadaschik B
    Urologe A; 2016 Feb; 55(2):146-55. PubMed ID: 26556268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
    Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
    BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Parameters Identifying Men Eligible for a Sole MRI/Ultrasound Fusion-Guided Targeted Biopsy without an Additional Systematic Biopsy.
    Günzel K; Haas M; Maxeiner A; Stephan C; Buckendahl J; Asbach P; Miller K; Kempkensteffen C; Cash H
    Urol Int; 2017; 98(1):15-21. PubMed ID: 27618633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of power doppler and ultrasound contrast agents in early imaging-based diagnosis of organ-confined prostate cancer: Is it possible to spare cores with contrast-guided biopsy?
    Delgado Oliva F; Arlandis Guzman S; Bonillo García M; Broseta Rico E; Boronat Tormo F
    Eur J Radiol; 2016 Oct; 85(10):1778-1785. PubMed ID: 27666616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.
    Baur ADJ; Schwabe J; Rogasch J; Maxeiner A; Penzkofer T; Stephan C; Rudl M; Hamm B; Jung EM; Fischer T
    Eur Radiol; 2018 May; 28(5):1949-1960. PubMed ID: 29238867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.
    Puech P; Rouvière O; Renard-Penna R; Villers A; Devos P; Colombel M; Bitker MO; Leroy X; Mège-Lechevallier F; Comperat E; Ouzzane A; Lemaitre L
    Radiology; 2013 Aug; 268(2):461-9. PubMed ID: 23579051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional Targeted Biopsy in Clinically Suspected Prostate Cancer: Prospective Randomized Comparison between Contrast-Enhanced Ultrasound and Sonoelastography Guidance.
    Koh J; Jung DC; Oh YT; Yoo MG; Noh S; Han KH; Rha KH; Choi YD; Hong SJ
    Ultrasound Med Biol; 2015 Nov; 41(11):2836-41. PubMed ID: 26298036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
    Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
    BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary magnetic resonance imaging/ultrasonography fusion-guided biopsy of the prostate.
    Maxeiner A; Kittner B; Blobel C; Wiemer L; Hofbauer SL; Fischer T; Asbach P; Haas M; Penzkofer T; Fuller F; Miller K; Cash H
    BJU Int; 2018 Aug; 122(2):211-218. PubMed ID: 29569320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Ipsilateral and Contralateral Transrectal Ultrasound-guided Systematic Prostate Biopsy in Men With Unilateral Magnetic Resonance Imaging Lesion Undergoing Magnetic Resonance Imaging-ultrasound Fusion-targeted Prostate Biopsy.
    Bryk DJ; Llukani E; Taneja SS; Rosenkrantz AB; Huang WC; Lepor H
    Urology; 2017 Apr; 102():178-182. PubMed ID: 27871829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeat Targeted Prostate Biopsy under Guidance of Multiparametric MRI-Correlated Real-Time Contrast-Enhanced Ultrasound for Patients with Previous Negative Biopsy and Elevated Prostate-Specific Antigen: A Prospective Study.
    Jang DR; Jung DC; Oh YT; Noh S; Han K; Kim K; Rha KH; Choi YD; Hong SJ
    PLoS One; 2015; 10(6):e0130671. PubMed ID: 26083348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.